Vlad Ratziu  
Co-Editor

Vlad Ratziu, MD, PhD is professor of hepatology at the Sorbonne Université and the Hôpital Pitié-Salpêtrière Medical School in Paris, France since 2004. He completed his medical training at the Université Paris Descartes in 1994, a postdoctoral fellowship at the Liver Center at the University of California in San Francisco, 1994-1996 and earned a doctoral degree from Université Paris Diderot for his work on the pathophysiology of viral and metabolic liver fibrosis 2003.

Dr. Ratziu’s main research interests are in the field of nonalcoholic fatty liver disease (NAFLD); the mechanisms, risk factors, and progression of liver fibrosis in viral and metabolic diseases; and the treatment of viral hepatitis and hepatocellular carcinoma. He coordinated the FLIP (Fatty Liver Inhibition of Progression) consortium, a program funded by the European 7th Framework Programme (FP7). He is part of the Steering Committee of the Horizon 2020 NASH EPoS and the IMI2 LITMUS Consortia. He is an associate editor for Clinical Liver Diseases. He currently serves as a Member of the International Advisory Board de The Lancet Gastroenterology & Hepatology

He is part of the organizing Committee of the NASH-TAG meetings.

Advertisement